PT Kalbe Farma Tbk. (FRA:LCLA)
Germany flag Germany · Delayed Price · Currency is EUR
0.0545
-0.0010 (-1.80%)
At close: Dec 5, 2025

PT Kalbe Farma Tbk. Company Description

PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia.

The company operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic segments.

The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business; and E-health products.

It operates Mitrasana Clinics, a health care service. In addition, the company provides health screening services; operates as an agent and representative for biotechnology products; distributes consumer products, medical equipment, cosmetics, and other trading products; and trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical products, and consumable products for hemodialysis therapy, as well as offers advertising services.

The company was incorporated in 1966 and is headquartered in Jakarta, Indonesia.

PT Kalbe Farma Tbk.
Country Indonesia
Founded 1966
Industry Pharmaceutical Preparations
Employees 12,903
CEO Bernadette Ruth Setiady

Contact Details

Address:
Gedung KALBE
Jakarta, 10510
Indonesia
Phone 62 21 4287 3888
Website kalbe.co.id

Stock Details

Ticker Symbol LCLA
Exchange Frankfurt Stock Exchange
Fiscal Year January - December
Reporting Currency IDR
SIC Code 2834

Key Executives

Name Position
Bernadette Ruth Setiady Chief Executive Officer